Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

Funding Opportunities

Extramural Grant Review Opportunity Available

Writing a grant? Need another set of eyes?

The Masonic Cancer Center Science Council can appoint individuals to review cancer center faculty members' grant drafts* or grant ideas in a face-to-face setting or in writing, depending on the stage of grant development. The goal is to improve upon members' success in obtaining grants funded by the NCI, ACS, and other national cancer research organizations.

To request a review, contact Aaron Schilz,, 624-0650.

*Members should submit their ideas or abstracts and specific aims one cycle (~3-4 months minimum) before the grant is due. We will usually provide feedback within 1 week.

News & Notices

NIH Issues 2014 Funding Levels
Non-competing continuation awards that have already been made in FY 2014 were generally funded at levels below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). Such reductions may be fully or partially restored, depending on the Institute or Center.  Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2014 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level.

NIH Publication Compliance and RPPR Progress Reports
Click on the title of this notice for a PDF containing a list of several helpful resources for navigating, monitoring, and managing publication compliance. For more information or questions, please contact Aaron Schilz, Research Grant Coordinator,

Notice of Intent to Publish a Funding Opportunity Announcement for Physical Sciences-Oncology Centers Program (U54)
National Cancer Institute

NIH Salary Cap increases to $181,500 Effective January 14, 2014
By Executive Order 13655

Funding Opportunities

American Cancer Society Institutional Research Grant applications are being accepted until April 18, 2014. This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes cancer etiology, mechanisms of carcinogenesis and chemoprevention, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic or chemoprevention models and translational research, cancer immunology and immunotherapy. This is a one-year seed grant. Funding is available up to $30,000. Applications may be obtained by emailing a request to . For information, please call Aaron Schilz, 612-624-0650.

THE U OF M INFORMATICS INSTITUTE (UMII) has announced two major funding initiatives at the interface of informatics and its applications: the UMII Transdisciplinary Research Fellowship will position recently promoted associate professors to provide leadership in transdisciplinary collaborative projects, and the UMII Faculty in Industry Fellowship will enable faculty to build strong partnerships with Minnesota businesses or agencies to develop long-term projects that address critical societal challenges. For more information, see UMII .

Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)
National Cancer Institute
Funding: Standard R01 limits apply.
Application Receipt Date(s): Multiple dates, see announcement.

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)
National Cancer Institute
Funding: Standard R21 limits apply
Deadline: June 30, 2014; see announcement for additional dates.

Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)
National Cancer Institute
Funding: $500,000/yr for 5 years
Application Receipt Date(s): Multiple dates, see announcement

CCRF Pediatric Cancer Research Projects (PDF)
Children’s Cancer Research Fund
Funding: $100,000 total for up to 2 years
Deadline: April 4, 2014

Scholar Awards
Jimmy V Foundation
Funding: $200,000 over 2 years
Internal Selection Deadline: March 14, 2014
Notification of Selected Applicant: March 18, 2014
Application Receipt Date(s): April 8, 2014

2014 Spring Research Grants
Alex’s Lemonade Stand Foundation

Bridge Grants
Deadline: April 10, 2014
Funding: $100,000 for 1 year
This grant is designed to sustain research projects falling between the end of funding by the National Institutes of Health (NIH) R or P Award and the beginning of a competitively renewed NIH Award. Renewal applications which scored less than or equal to the 35th percentile but were not funded will be eligible for Bridge Grants. Applicants must have a plan to resubmit for NIH funding.

Springboard Grants
Deadline: April 10, 2014
Funding: $100,000 for 1 year
This grant supports new National Institutes of Health (NIH) R01 or P01 research applications which were scored less than or equal to the 25th percentile but were not funded. Applicants must have a plan to resubmit for NIH funding.

'A' Awards
Deadline: May 23, 2014
Funding: $450,000 over 3 years
Designed for early career scientists with an original project who can demonstrate outstanding mentorship and have a strong future commitment to pediatric cancer investigation.

Reach Awards
Deadline: May 30, 2014
Funding: $250,000 over 2 years
The goal of this award is to support selected "late translational" studies needed to ultimately initiate a clinical trial. A successful application will identify an unmet clinical need relevant to the care of pediatric cancer patients and describe how the proposed project will allow for the pre-clinical research to be translated to the clinic while keeping broader clinical testing and implementation in view. Maximum of $250,000 in total costs awarded over two years. 

Woman to Woman Program Grant
Ovarian Cancer Research Fund
Funding: $50,000/yr
Deadline: May 1, 2014
Woman to Woman is a free support program that pairs gynecologic cancer patients with professionally trained and supervised survivor volunteers. This one-on-one emotional support and mentoring program provides much-needed services to women and families through all phases of treatment, recurrence, and recovery, and is offered free of charge to all participants.

2014 MOCA Ovarian Cancer Research Grants
Minnesota Ovarian Cancer Alliance
Full Application Deadline: March 7, 2014
Funding: $100,000 for 1 year

Mentored Career Development Award in Biomedical Big Data Science for Clinicians and Doctorally Prepared Scientists (K01)
National Cancer Institute
Application Receipt Date(s): April 1, 2014; April 1, 2015
Funding: NIH will contribute up to $167,000 per year toward the salary of the career award recipient, and $40,000 in research expenses per year.

Breath of Hope Research Fellowships
A Breath of Hope Lung Foundation
Deadline: April 1, 2014, 11:59 p.m. CST.
Funding: $150,000/two years
Focus is on researchers who are conducting translational lung cancer research that will lead to patient care/clinical trial within three to five years.

Using Social Media to Understand and Address Substance Use and Addiction
R01 (RFA-CA-14-008)
R21 (RFA-CA-14-009)
National Cancer Institute
Application Receipt Date(s): March 25, 2014
Funding: Standard limits apply. 

Funding for High-Impact Pediatric Cancer Research
Sponsor: Solving Kids’ Cancer Foundation
Clinical Idea of Intent Deadline: open-ended (through 2014 calendar year)
Proposal Deadline: notification to fully submit will occur 5 weeks after intent submisison
Amount: $50,000 - $600,000 depending on scope

Modeling Social Behavior (R01)
National Cancer Institute
Deadline: Multiple dates, see announcement.
Funding: Standard R01 limits apply.

Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
National Cancer Institute
Deadline: March 20, 2014; March 19, 2015; March 22, 2016
Funding: Standard R01 limits apply.

TTR Core Usage Funding Program
Sponsor: Office of Discovery and Translation - CTSI
Application Deadline (ongoing): 5 p.m. on the 10th day of any month
Funding: up to $10,000 to use a TTR-designated Core Resource for up to one year
The Core Usage Funding Program is designed to support clinical or translational projects. Basic research projects are ineligible. The supported studies may be either pilot projects, intended to generate preliminary data for larger studies, or projects nearing the final stages of completion but now require additional data the Core Resources can generate. It is expected that a Core Usage grant will be used to generate data to support an external grant submission or patent application.

Pancreatic Cancer Action Network Research Grants Program
Sponsor: Pancreatic Cancer Action Network and American Association for Cancer Research
Deadlines: Multiple; see announcement
Funding: See announcement
Funding is available for postdoctoral/clinical research fellows as well as for junior and senior independent researchers. The proposed research must be directly relevant to pancreatic cancer. More information about the grants program, including eligibility criteria and application due dates and procedures, is available at

Notice of Intent to Publish a Funding Opportunity Announcement for "Cancer Detection, Diagnostic and Treatment Technologies for Global Health (UH2/UH3)
National Cancer Institute
FOA is expected to be published in Fall 2013 with an application deadline in Winter 2014.
This FOA will solicit applications for the development of new technologies/devices and/or adaptation of existing technologies/devices for cancer detection/diagnosis and treatment to be tested and ultimately implemented in low- and middle-income countries (LMICs), as listed by World Bank (

Research to Characterize and Reduce Stigma to Improve Health
R01 (PA-13-248)
R03 (PA-13-247)
R21 (PA-13-246)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.  Standard cycle dates.
Funding: Standard limits apply

Tobacco Control Regulatory Research
R01 (RFA-OD-13-011)
R03 (RFA-OD-13-012)
R21 (RFA-OD-13-010)
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
Application Receipt Date(s): June 17, 2014, January 16, 2015
Funding: R01 - $499,999 direct costs per year; standard limits for R03 and R21 applications.

Prostate Cancer Research Program (PCRP)
Sponsor: Department of Defense
Deadlines: Various; see announcements
Funding: See announcements

Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness
R01 (PA-13-165)
R15 (PA-13-166)
R21 (PA-13-167)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard limits apply. See announcements for additional information.

Bioengineering Research Grants (BRG) (R01)
National Cancer Institute
Application Deadline: Multiple receipt dates, see announcement. 
Funding: Standard R01 limits apply

The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)
National Cancer Institute
Application Receipt Date(s): November 14, 2014
Funding: 5 years, application budgets are not limited, but need to reflect the actual needs of the proposed project.

Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: standard R01 limits apply

Research Funding Resources
  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on March 4, 2014